MiR-153 inhibits the resistance of lung cancer to gefitinib via modulating expression of ABCE1
{{output}}
Background: Gefitinib-resistance in lung cancers has become an intractable clinical problem. However, the mechanisms underlying this resistance are not fully understood. ... ...
